In Our Own Words: The Complex Sensory Experiences of Autistic Adults

por MacLennan, K., O’Brien, S., Tavassoli, T.
Publicado 2021

Expression of CD44 by rhabdomyosarcoma: a new prognostic marker?

por Humphrey, G, Hazel, D L, MacLennan, K, Lewis, I
Publicado 1999

Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy.

por Vaughan Hudson, B., Vaughan Hudson, G., MacLennan, K. A., Anderson, L., Linch, D. C.
Publicado 1994

Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's di...

por Swerdlow, A. J., Douglas, A. J., Vaughan Hudson, G., Vaughan Hudson, B., MacLennan, K. A.
Publicado 1993

Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia

por Nankivell, P, Williams, H, McConkey, C, Webster, K, High, A, MacLennan, K, Senguven, B, Rabbitts, P, Mehanna, H
Publicado 2013

Primary gastrointestinal non-Hodgkin's lymphoma: a review of 175 British National Lymphoma Investigation cases.

por Morton, J. E., Leyland, M. J., Vaughan Hudson, G., Vaughan Hudson, B., Anderson, L., Bennett, M. H., MacLennan, K. A.
Publicado 1993

British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin'...

por Hancock, B. W., Vaughan Hudson, G., Vaughan Hudson, B., Haybittle, J. L., Bennett, M. H., MacLennan, K. A., Jelliffe, A. M.
Publicado 1991

Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.

por Gore, M. E., Riches, P., MacLennan, K., O'Brien, M., Moore, J., Dadian, G., Lorentzos, A., Garth, R., Moskovic, E., Archer, D.
Publicado 1992

Prostate-specific membrane antigen: evidence for the existence of a second related human gene.

por Leek, J., Lench, N., Maraj, B., Bailey, A., Carr, I. M., Andersen, S., Cross, J., Whelan, P., MacLennan, K. A., Meredith, D. M.
Publicado 1995

Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.

por Patel, P. M., Flemming, C. L., Russell, S. J., McKay, I. A., MacLennan, K. A., Box, G. M., Eccles, S. A., Collins, M. K.
Publicado 1993

A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma

por Burton, C, Linch, D, Hoskin, P, Milligan, D, Dyer, M J S, Hancock, B, Mouncey, P, Smith, P, Qian, W, MacLennan, K, Jack, A, Webb, A, Cunningham, D
Publicado 2006

A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National...

por Linch, D. C., Vaughan Hudson, B., Hancock, B. W., Hoskin, P. J., Cunningham, D. C., Newland, A. C., Milligan, D. W., Stevenson, P. A., Wood, J. K., MacLennan, K. A., Anderson, L., Gregory, W. M., Vaughan Hudson, G.
Publicado 1996